Lung Cancer Treatment Advances in 2022-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lung Cancer Treatment Advances in 2022

Published:2022-12-12 Issue:1 Volume:41 Page:12-24
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Abu Rous Fawzi¹,Singhi Eric K.²,Sridhar Arthi³,Faisal Muhammad Salman⁴,Desai Aakash⁵

Affiliation:

1. Department of Internal Medicine, Division of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA

2. Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Division of Hematology and Oncology, University of Texas Health Sciences Center at Houston, Houston, Texas, USA

4. Fellow Department of Hematology and Medical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA

5. Division of Medical Oncology, Mayo Clinic, Rochester, New York, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2022.2119479

Reference29 articles.

1. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

2. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

3. Fall in US cancer death rates: Time to pop the champagne?

4. Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal role of immune cells in lung cancer subtypes: Mendelian randomization study;Human Immunology;2024-09

2. The association between human papillomavirus and lung cancer: A Mendelian randomization study;Infection, Genetics and Evolution;2024-09

3. [177Lu]Lu DOTATOC PRRT with PARP inhibitors in small cell lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-27

4. Mechanism study of serum extracellular nano-vesicles miR-412-3p targeting regulation of TEAD1 in promoting malignant biological behavior of sub-centimeter lung nodules;Cancer Biomarkers;2024-08-23

5. Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications;Anti-Cancer Agents in Medicinal Chemistry;2024-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3